Formononetin mitigates age-related sarcopenia by blocking mitochondrial ferroptosis via SIRT1/PGC-1α signaling
The International Journal of Biochemistry & Cell Biology · 2026
DOI: 10.1016/j.biocel.2026.107014 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2026. Verfasst von Xiao Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Ha…. Hauptthemen laut MEDLINE: Sirtuin 1, Sarcopenia, Ferroptosis, Signal Transduction. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Science and Technology Department of Zhejiang Province.
Abstract (Originalsprache)
Age-related muscle atrophy is closely associated with mitochondrial dysfunction and ferroptosis. This study established a D-gal-induced sarcopenia model in aged mice and a C2C12/GM17940 cell myotube senescence model, with young/control, old/D-gal, and formononetin (FMN) intervention groups. After shSIRT1 transfection and mitochondrial-targeted antioxidant Mito-C intervention, the effects and mechanism of FMN were detected by measuring mouse phenotypic indicators (lean mass, hindlimb muscle mass, grip strength) and cell indicators (viability, mitochondrial membrane potential, ROS, ATP, ferroptosis-related proteins). Results showed that FMN improved lean mass, grip strength, mitochondrial membrane potential, and ATP production, while reducing ROS and ferroptosis by regulating ACSL4, GPX4, and SLC7A11. Mechanistically, FMN exerted protective effects via the SIRT1/PGC-1α pathway, which was partially attenuated by SIRT1 knockdown or Mito-C. Collectively, FMN alleviates age-related sarcopenia by targeting mitochondrial function and ferroptosis, providing potential targets for sarcopenia treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.
- The First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
- Department of Cardiology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.
- School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
- Department of Geriatrics, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China. Electronic address: Songwenwi_sww123@163.com.
Förderung
- Science and Technology Department of Zhejiang Province
Zitieren
APA
Wang, X., Zhong, L., Yang, J., Xiong, W., Pan, Z., Ding, W., & Song, W. (2026). Formononetin mitigates age-related sarcopenia by blocking mitochondrial ferroptosis via SIRT1/PGC-1α signaling. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/j.biocel.2026.107014
Vancouver
Wang X, Zhong L, Yang J, Xiong W, Pan Z, Ding W, et al. Formononetin mitigates age-related sarcopenia by blocking mitochondrial ferroptosis via SIRT1/PGC-1α signaling. The International Journal of Biochemistry & Cell Biology. 2026. doi:10.1016/j.biocel.2026.107014
BibTeX
@article{Wang2026,
author = {Wang, Xiao and Zhong, Linhan and Yang, Jun and Xiong, Weizhu and Pan, Zhimin and Ding, Wei and Song, Wenwei},
title = {Formononetin mitigates age-related sarcopenia by blocking mitochondrial ferroptosis via SIRT1/PGC-1α signaling},
journal = {The International Journal of Biochemistry & Cell Biology},
year = {2026},
doi = {10.1016/j.biocel.2026.107014}
}
EUVIMED